Zenas BioPharma, Inc. (ZBIO)
NASDAQ·Healthcare·Biotechnology
$29.83
-9.74%
Mkt Cap $2.02B
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (7 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
-26.2%
Consensus $22.00 vs current $29.83
NASDAQ·Healthcare·Biotechnology
$29.83
-9.74%
Mkt Cap $2.02B
Buy
3
Hold
2
Sell
0
Price Target (7 analysts)
$22.00
Range $22.00 – $22.00
-26.2%
Consensus $22.00 vs current $29.83